Answers are grounded in this paper and cite their sources.
This study aimed to characterize ethnic-group differences in the distribution of reported adverse drug reactions (ADRs) and identify factors associated with moderate-to-severe reported ADRs in a hospital pharmacovigilance database. This retrospective database study included 1552 eligible ADR reports submitted at Xichang People’s Hospital between May 2022 and April 2025. Reports were classified by age, sex, recorded ethnicity, drug category, administration route, affected organ system, and Hartwig severity grade. Overall group comparisons used the Fisher–Freeman–Halton exact test or Kruskal–Wallis H test, with Bonferroni-adjusted pairwise analyses. Hartwig levels 1 to 2 were classified as mild and levels 3 to 7 as moderate-to-severe for multivariable logistic regression. Han, Yi, and other ethnic groups accounted for 938 (60.44%), 567 (36.53%), and 47 (3.03%) reports, respectively. Sex distribution and administration route did not differ significantly among the groups, whereas age distribution, drug category, affected organ system, and ordinal Hartwig grade differed overall. Pairwise differences in Hartwig grade did not remain significant after Bonferroni correction. In the adjusted model, recorded ethnicity was not independently associated with moderate-to-severe reported ADRs. Older age, selected drug categories and administration routes, and several affected organ systems were associated with the outcome. The characteristics of reported ADRs differed across recorded ethnic groups, but ethnicity was not independently associated with moderate-to-severe reactions after adjustment. These findings describe patterns among submitted ADR reports and do not estimate population-level ADR incidence.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: